← All trials
NCT07131345
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2025
- Primary completion
- Oct 31, 2026
- Completion date
- Jul 1, 2027
- First posted
- Aug 20, 2025
- Last posted
- Aug 20, 2025
- Enrollment
- 55
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Cancer Center, ChinaLead sponsor
- Capital Medical UniversityCollaborator
- National Cancer Center, ChinaOfficial
- Shaanxi Provincial People's HospitalCollaborator
- Zhengzhou UniversityCollaborator
- Qilu Pharmaceutical Co., Ltd.Collaborator
- National Cancer Center, ChinaSponsor investigator
- Inner Mongolia Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.